FDA Halts Gilead’s Magrolimab Blood Cancer Trials

FDA Halts Gilead’s Magrolimab Blood Cancer Trials

In a recent development, Gilead Sciences has faced a setback as the U.S. health regulator, the Food and Drug Administration…

Read More »